Clinical Trial Update: An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing dolutegravir plus lamivudine versus dolutegravir plus tenofovir/emtricitabine in treatment-naïve HIV patients has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Dolutegravir + Tenofovir/Emtricitabine
• Dolutegravir/Lamivudine (dolutegravir/lamivudine)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus, HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2019-04-18